Nothing yet..
This doctor has not yet uploaded content to this section
Load More
Dr. Daniel Layish graduated Magna cum Laude from Boston University School of Medicine in 1990. He then completed a Residency in Internal Medicine at Barnes Hospital (Washington University) in St. Louis followed by a Pulmonary/Critical Care/Sleep Fellowship at Duke. He joined the Central Florida Pulmonary Group in Orlando in 1997 and currently serves as their Vice President, Medical Director of Clinical Research and Co-Director of the Adult Cystic Fibrosis Program. He is Past-President of the Southeastern Thoracic Association.
MD: Boston University School of Medicine (Magna cum Laude)
Residency in Internal Medicine: Barnes Hospital (Washington University) in St. Louis
Pulmonary/Critical Care/Sleep Fellowship: Duke University
Board Certified in Internal Medicine
Board Certified in Pulmonary Disease
Board Certified in Critical Care Medicine
Board Certified in Sleep Medicine
Article
This article originally ran in FloridaMD Magazine in the August 2014 issue. Rheumatoid arthritis (RA) is a systemic autoimmune process classically known for chronic symmetrical erosive synovitis. It is generally progressive. Lungs are the site...
Read ArticleArticle
This article originally ran in FloridaMD magazine in the February 2016 issue. There are several categories of pulmonary hypertension. WHO Group I includes patients with idiopathic pulmonary hypertension, familial pulmonary hypertension, drug and toxin related (fen-phen)...
Read ArticleArticle
This article originally ran in FloridaMD magazine in the January 2014 issue. Physicians are well aware that cigarette smoking is the leading preventable cause of mortality. It is also well known that when smokers stop smoking...
Read ArticleArticle
This article originally ran in FloridaMD magazine in the September 2011 issue. SHAPE testing is a promising technology that simplifies cardiopulmonary exercise testing to allow better and easier evaluation of patients with cardiopulmonary diseases. SHAPE:...
Read ArticleArticle
This article originally ran in FloridaMD magazine in the January 2016 issue. The FDA approved omalizumab (Xolair) in 2003 to treat patients with asthma and an elevated IgE level. Recently, the FDA approved mepolizumab (brand name...
Read ArticleArticle
This article originally ran in FloridaMD magazine in the March 2016 issue. Pulmonary rehabilitation can benefit patients with a wide variety of lung diseases including COPD, pulmonary fibrosis, cystic fibrosis, and sarcoidosis (among other chronic respiratory...
Read ArticleArticle
This article originally ran in FloridaMD magazine in the July 2015 issue. The word Halotherapy comes from the Greek word “halos” meaning salt. While the potential benefits and therapeutic nature of salt has been known for...
Read ArticleArticle
This article originally ran in FloridaMD magazine in the November 2014 issue and was co-written by Jeffrey Phillips, MD Obstructive sleep apnea (OSA) is a very prevalent condition. It has been estimated to occur in up...
Read ArticleThis doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
This doctor has not yet uploaded content to this section
1115 East Ridgewood Street, Orlando, FL 32803, USA
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.